Omaha, Neb.

Went public on 7/18/2000 at $15 per share

Filing Range: 4 mil. shares @ $12 to $14

Share Outstanding: 17.33 mil. shares

Underwriters: Chase H&Q/Bear, Stearns & Co./Dain Rauscher Wessels

Company Counsel: Kutak Rock

Manager Counsel: Milbank Tweed Hadley & McCloy LLP

Auditor: Deloitte & Touche LLP

The Company:

Designs and manufactures a broad range of chromatography products, sample introduction and detection products, and on-line process monitoring systems, under the name CETAC Technologies. The company’s core biotechnology business includes principle technologies for DNA/RNA and protein analysis and separations.

Venture Backers:

Granite Ventures LLC

Financing Rounds:

Number of Round Amt.

Round # Round Date Stage Investors ($ thousands)

1 03/24/1999 1 Early Stage 300.0


(Data in $ millions)



Total Revenues: $23.0

Net Income: -9.8